The industrial biotech has punched its ticket to the cannabis party, but investors shouldn't get too excited just yet.
The uranium miner and fuel fabricator has battened down the hatches to weather dismal market fundamentals in recent years. Is this the year the efforts pay off?
Shares of the fuel cell manufacturer have gained almost 50% so far in 2019, but a continued rise isn't quite a certainty.
The company announced preliminary full-year 2018 results that fell below Wall Street's expectations.
The pharma company bounced around for much of 2018, but there's intriguing potential in the pipeline.
Long-term investing is a solid way to build wealth. Penny stocks? Not so much.
The company just licensed four drug programs for a cool $165 million up-front payment -- with the potential to receive $1.7 billion in future milestone payments.
The basic materials company has agreed to merge with a competitor to create a $9 billion behemoth.
A dam owned by the company collapsed in Brazil, leaving over 60 people dead and nearly 300 missing.
A quirky financial accounting rule is helping to keep America's coal-fired power plants open.
This small-cap stock had a rough 2018, but the company just launched its first drug product. Will it be enough to regain Wall Street's trust?
The company cemented its leadership position in the solar market and grew hand over fist last year. It wasn't enough for Wall Street. Will that change this year?
An investigative report is shining light on some very serious questions about the company. Shareholders absolutely must read it.
The pharma company announced the pricing of a share offering, but the cash will help to launch a promising new drug for cancer patients.
The $600 million pharma company is working on a drug with estimated peak annual sales of $500 million.
After March 1, the company will be solely focused on agricultural sciences. It'll need to get to work quickly to shore up its pipeline.
The company announced the pricing of a share offering announced the day before.
The industrial powerhouse expects the aluminum market to grow at its slowest pace since the Great Recession. What will that mean for the business?
The world's premier lithium producer is struggling to convince Wall Street of its growth potential, but investors can watch for these signs of progress.
Start the year off the right way by injecting some long-term growth potential into your portfolio with one (or all) of these stocks.